Search results
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid...
KTLA-TV Los Angeles· 6 days agoYS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations ...
Arendt Chic | Opinion
The Wichita Eagle· 1 day agoEditorials and other Opinion content offer perspectives on issues important to our community and are independent from the work of our newsroom reporters. Stonebridge's book fails by attempting ...